Your browser doesn't support javascript.
loading
UBE2T is a diagnostic and prognostic biomarker for endometrial cancer.
Wang, Longyun; Wang, Mengqi; Wang, Zeyu; Wang, Kai; Zhao, Bowei; Wang, Yue; Zheng, Jingying; Zhang, Shuang.
Affiliation
  • Wang L; Department of Rehabilitation, School of Nursing, Jilin University, Changchun, 130021, Jilin, China.
  • Wang M; Department of Reproductive Medicine, The Third Affiliated Hospital of Zhengzhou University, Zhengzhou, 450052, Henan, China.
  • Wang Z; Department of Rehabilitation, School of Nursing, Jilin University, Changchun, 130021, Jilin, China.
  • Wang K; Department of Rehabilitation, School of Nursing, Jilin University, Changchun, 130021, Jilin, China.
  • Zhao B; Department of Rehabilitation, School of Nursing, Jilin University, Changchun, 130021, Jilin, China.
  • Wang Y; Department of Rehabilitation, School of Nursing, Jilin University, Changchun, 130021, Jilin, China.
  • Zheng J; Department of Gynecology and Obstetrics, The Second Hospital of Jilin University, Changchun, 130000, Jilin, China. zheng_jy@jlu.edu.cn.
  • Zhang S; Department of Rehabilitation, School of Nursing, Jilin University, Changchun, 130021, Jilin, China. zhangs@jlu.edu.cn.
Clin Transl Oncol ; 2024 Oct 05.
Article in En | MEDLINE | ID: mdl-39367897
ABSTRACT

BACKGROUND:

Endometrial cancer (UCEC) is one of the most common malignant tumors in gynecology, and early diagnosis is crucial for its treatment. Currently, there is a lack of early screening tests specific to UCEC, and treatment advances are limited. It is crucial to identify more sensitive biomarkers for screening, diagnosis, and predicting UCEC. Previous studies have shown that UBE2T is involved in the development of various tumors such as breast cancer and liver cancer, but research on the role of UBE2T in UCEC is limited.

METHODS:

Using data from The Cancer Genome Atlas (TCGA), Gene Expression Omnibus (GEO), and UALCAN databases, we analyzed the differential expression of UBE2T mRNA and protein in endometrial cancer (UCEC), along with its clinical relevance. A total of 113 clinical samples were collected, and immunohistochemistry and Western blot analysis were employed to validate bioinformatics analysis results. Volcano plots were generated using UBE2T and its differentially expressed genes, and a protein-protein interaction (PPI) network was constructed. Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes (KEGG), gene set enrichment analysis (GSEA), and immune infiltration analysis were used to predict the functional role of UBE2T in UCEC progression. Correlation between UBE2T expression and patient survival was analyzed using TCGA data, and Kaplan-Meier survival curves were plotted.

RESULTS:

UBE2T is significantly overexpressed in UCEC and correlates with poor prognosis. Its overexpression is closely associated with mitosis, cell cycle regulation, and histological grade in UCEC patients.

CONCLUSION:

UBE2T is highly expressed in UCEC and suppresses anti-tumor immune responses in UCEC patients. It serves as a key participant in UCEC progression, associated with a range of adverse outcomes, and holds potential as a clinical diagnostic and prognostic biomarker.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Transl Oncol Year: 2024 Document type: Article Affiliation country: China Country of publication: Italy

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Clin Transl Oncol Year: 2024 Document type: Article Affiliation country: China Country of publication: Italy